CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription

Control of RNA polymerase II (RNA Pol II) through ubiquitylation is essential for the DNA-damage response. Here, we reveal a distinct ubiquitylation pathway in human cells, mediated by CRL3<sup>ARMC5</sup>, that targets excessive and defective RNA Pol II molecules at the initial stages of the transcription cycle. Upon ARMC5 loss, RNA Pol II accumulates in the free pool and in the promoter-proximal zone but is not permitted into elongation. We identify Integrator subunit 8 (INTS8) as a gatekeeper preventing the release of excess RNA Pol II molecules into gene bodies. Combined loss of ARMC5 and INTS8 has detrimental effects on cell growth and results in the uncontrolled release of excessive RNA Pol II complexes into early elongation, many of which are transcriptionally incompetent and fail to reach the ends of genes. These findings uncover CRL3<sup>ARMC5</sup> and Integrator as two distinct pathways acting in parallel to monitor the quantity and quality of transcription complexes before they are licensed into elongation.

Authors

Institutions

Publication Details

Journal
Molecular Cell
Published
2024-12-01
DOI
https://doi.org/10.1016/j.molcel.2024.11.024
Citations
15
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
3.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription

Julian E. Sale, Ana Tufegdžić Vidaković, Daniela Castiblanco, Alastair Crisp et al.
15 citations
Molecular Cell
Ubiquitin and proteasome pathways
3.51
article

CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription

Julian E. Sale, Ana Tufegdžić Vidaković, Daniela Castiblanco, Alastair Crisp, Roberta Cacioppo, Angela Arabiotorre, Alexander Gillis, Iván Shlamovitz, Pegah Abyaneh, Yu Bao, Scott Michael Berry, Andrew Zeller, Benjamin Haworth
article en
15 citations

Abstract

Control of RNA polymerase II (RNA Pol II) through ubiquitylation is essential for the DNA-damage response. Here, we reveal a distinct ubiquitylation pathway in human cells, mediated by CRL3<sup>ARMC5</sup>, that targets excessive and defective RNA Pol II molecules at the initial stages of the transcription cycle. Upon ARMC5 loss, RNA Pol II accumulates in the free pool and in the promoter-proximal zone but is not permitted into elongation. We identify Integrator subunit 8 (INTS8) as a gatekeeper preventing the release of excess RNA Pol II molecules into gene bodies. Combined loss of ARMC5 and INTS8 has detrimental effects on cell growth and results in the uncontrolled release of excessive RNA Pol II complexes into early elongation, many of which are transcriptionally incompetent and fail to reach the ends of genes. These findings uncover CRL3<sup>ARMC5</sup> and Integrator as two distinct pathways acting in parallel to monitor the quantity and quality of transcription complexes before they are licensed into elongation.

Molecular CellVol. 84(24)
MRC Laboratory of Molecular Biology (GB), UNSW Sydney (AU), EMBL Australia (AU)
Australian Government, Cancer Research UK, Boehringer Ingelheim Fonds, Darwin Trust of Edinburgh, Medical Research Council, Australian Research Council
Openalex Percentile: Top 6%
Ubiquitin and proteasome pathways
3.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.